In patients with acute coronary syndromes (ACS), assessing the Syntax score after percutaneous coronary intervention (PCI) quantifies the extent and complexity of residual stenosis and may identify ...

In patients with moderate- and high-risk acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI), the Syntax score predicts 1-year ischemic outcomes including mortality, ...

Compared with the classic SYNTAX score, the functional SYNTAX score decreased the number of higher-risk patients and better discriminated risk for adverse events in patients with multivessel coronary ...

Real-world registry data show that the SYNTAX score II 2020 (SSII-2020) reliably predicts mortality but not major adverse cardiovascular events (MACE) 5 years after stenting and coronary bypass ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PARIS -- With ...

Please provide your email address to receive an email when new articles are posted on . The functional SYNTAX score can be calculated noninvasively and is comparable to calculations using invasive ...

Should patients with high-risk coronary artery disease be treated with CABG or receive drug-eluting stents? The SYNTAX trial aimed to define the optimal revascularization strategy for patients with ...

The beneficial effect on all-cause mortality of coronary artery bypass grafting surgery (CABG) observed at 4 and 5 years in women with complex coronary disease seen in the SYNTAX trial is gone at 10 ...

The choice of revascularization strategy for patients with complex coronary artery disease (CAD) impacts patients' prognosis and quality of life, but the optimal strategy remains controversial ...

NATICK, Mass. and WASHINGTON, Oct. 14 BostonScientific Corporation (NYSE: BSX) today announced 12-month left main andthree-vessel disease subset data from its landmark SYNTAX trial ...

ORLANDO – November 4, 2021 – The primary results of the Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 trial found that percutaneous coronary intervention (PCI) guided ...